Validating a Nonhuman Primate Model of Super-Selective Intraophthalmic Artery Chemotherapy: Comparing Ophthalmic Artery Diameters
- 1 November 2012
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 53 (12) , 7791-7794
Abstract
Purpose. Superselective intraophthalmic artery chemotherapy (SSIOAC) is being used for treatment of retinoblastoma; however, the hemodynamic consequences and toxicities are not fully known. We developed a nonhuman primate (NHP) model of SSIOAC and reported our clinical observations. For validation, we compared ophthalmic artery (OA) diameters between NHPs and children (Methods. Endovascular cannulation of the right OA was performed three times each in six adult male Rhesus macaques. Angiographic OA images were obtained and measured, and postmortem OAs were histologically sectioned and measured. Retrospectively, computed tomography (CT) and magnetic resonance (MR) angiography images of the head in children and adolescents (as an adult reference) were used to measure the OA luminal diameter at its origin. Results. The median angiographic diameter of treated NHP OA origins (n = 6) was 1.06 mm (range 0.94–1.56). Histologic measurements (8 of 12 NHP OAs) gave a median diameter of 1.09 mm (range 0.95–1.41). In 98 children (from 169 consecutive CT and MR angiography studies; median age 1.01 years, range 0.01–5.74), 186 OAs were measurable at the origin (median luminal diameter 1.28 mm, range 0.82–2.00; P = 0.16 for the angiographic NHP diameters versus pediatric cohort). Angiographic measurements of 34 OAs (of 20 consecutive studies of adolescents; median age 16.55 years, range 14.40–18.18) gave a median luminal diameter of 1.45 mm (origin, range 1.13–1.66; P < 0.0001, adolescent versus pediatric). Conclusions. Measurements of the OA luminal diameter at its origin were similar between our NHP and pediatric cohort, validating our NHP model for testing both the hemodynamic consequences and toxicities of SSIOAC.Keywords
This publication has 29 references indexed in Scilit:
- Intra-Ophthalmic Artery Chemotherapy Triggers Vascular Toxicity through Endothelial Cell Inflammation and LeukostasisInvestigative Ophthalmology & Visual Science, 2012
- Real-Time Ophthalmoscopic Findings of Superselective Intraophthalmic Artery Chemotherapy in a Nonhuman Primate ModelArchives of Ophthalmology (1950), 2011
- Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumorsJournal of Neurosurgery, 2011
- OCCURRENCE OF SECTORAL CHOROIDAL OCCLUSIVE VASCULOPATHY AND RETINAL ARTERIOLAR EMBOLIZATION AFTER SUPERSELECTIVE OPHTHALMIC ARTERY CHEMOTHERAPY FOR ADVANCED INTRAOCULAR RETINOBLASTOMARetina, 2011
- Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastomaClinical Ophthalmology, 2011
- Intra‐arterial chemotherapy for retinoblastoma: the beginning of a long journeyClinical & Experimental Ophthalmology, 2010
- Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastomaMiddle East African Journal of Ophthalmology, 2010
- A microsurgical study of the anatomy and course of the ophthalmic artery and its possibly dangerous anastomosesJournal of Neurosurgery, 2007
- The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastomaInternational Journal of Clinical Oncology, 2004
- Studies of intracranial and orbital vasculature of the rhesus monkey (Macaca mulatta)The Anatomical Record, 1962